Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Y-mAbs Therapeutics, Inc. (YMAB)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
13 Dec 2023
Gad Thomas
Chief Business Officer, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
265,032
-36%
150,000
$6.67
$1,001,000.00
BUY
15 May 2023
WG Biotech ApS
Director, See remarks
Y-mAbs Therapeutics, Inc.
(YMAB)
4,280,205
+2%
101,740
$9.65
$981,404.44
BUY
15 May 2023
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,280,205
+2%
101,740
$9.65
$981,404.44
BUY
15 Nov 2022
Rajah Vignesh
SVP & CMO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
4,266
+38%
1,195
$4.92
$5,884.18
SELL
22 Feb 2022
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
181,077
-2%
4,000
$7.85
$31,400.00
SELL
7 Feb 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
565,032
-33%
281,170
$7.19
$2,021,188.10
SELL
4 Feb 2022
Kruse Bo
EVP, CFO, Secretary & Treas, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
185,077
-2%
4,000
$7.97
$31,880.00
SELL
3 Feb 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
846,202
-13%
136,164
$7.75
$1,055,557.80
SELL
1 Feb 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
50,000
-13%
8,000
$10.15
$81,160.80
SELL
24 Jan 2022
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
189,077
-2%
4,000
$9.84
$39,360.00
SELL
24 Jan 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,038,149
-7%
88,055
$10.63
$936,412.00
SELL
20 Jan 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,090,605
-14%
183,085
$11.10
$2,033,104.50
SELL
18 Jan 2022
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,253,506
-5%
77,814
$10.96
$852,990.40
SELL
4 Jan 2022
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
193,077
-2%
4,000
$17.12
$68,480.00
SELL
22 Dec 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
197,077
-1%
4,000
$16.36
$65,440.00
SELL
6 Dec 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
201,077
-1%
4,000
$16.35
$65,400.00
SELL
6 Dec 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,383,320
-3%
54,000
$16.69
$901,074.00
SELL
29 Nov 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,461,890
-3%
47,607
$17.11
$814,483.10
SELL
23 Nov 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
50,000
-50%
50,000
$17.06
$852,849.94
SELL
22 Nov 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
205,077
-1%
4,000
$18.09
$72,360.00
SELL
16 Nov 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,484,927
-0%
4,000
$19.33
$77,302.00
SELL
4 Nov 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
209,077
-1%
4,000
$27.54
$110,160.00
SELL
29 Oct 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,488,927
-0%
4,000
$24.82
$99,260.81
SELL
22 Oct 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
213,077
-1%
4,000
$25.94
$103,760.00
SELL
15 Oct 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,492,927
-0%
4,000
$27.20
$108,799.20
SELL
4 Oct 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
217,077
-1%
4,000
$28.78
$115,120.00
SELL
30 Sep 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,496,927
-0%
4,000
$28.26
$113,054.40
SELL
22 Sep 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
221,077
-1%
4,000
$30.82
$123,280.00
SELL
15 Sep 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,500,927
-0%
4,000
$33.64
$134,578.80
SELL
7 Sep 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
225,077
-1%
4,000
$32.03
$128,119.99
SELL
2 Sep 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,504,927
-3%
50,000
$33.18
$1,658,915.00
SELL
23 Aug 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
229,077
-1%
4,000
$28.60
$114,400.00
SELL
13 Aug 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,554,927
-1%
29,000
$29.35
$851,023.30
BUY
12 Aug 2021
Rajah Vignesh
SVP & CMO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
3,071
+80%
1,374
$29.95
$41,147.18
SELL
4 Aug 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
233,077
-1%
4,000
$33.72
$134,880.00
SELL
3 Aug 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,583,927
-0%
4,000
$33.73
$134,927.20
SELL
22 Jul 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
237,077
-1%
4,000
$34.50
$138,000.00
SELL
20 Jul 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,587,927
-0%
4,000
$32.47
$129,875.20
SELL
7 Jul 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,591,927
-0%
4,000
$31.87
$127,464.80
SELL
6 Jul 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
241,077
-1%
4,000
$34.15
$136,600.00
SELL
30 Jun 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,595,927
-0%
4,000
$33.86
$135,445.61
SELL
22 Jun 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
245,077
-1%
4,000
$36.17
$144,680.00
SELL
14 Jun 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,599,927
-0%
4,000
$35.80
$143,217.19
SELL
10 Jun 2021
WG Biotech ApS
Director, See remarks
Y-mAbs Therapeutics, Inc.
(YMAB)
4,178,456
-0%
11,229
$36.15
$405,971.03
SELL
10 Jun 2021
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,178,465
-0%
11,229
$36.15
$405,971.03
SELL
8 Jun 2021
WG Biotech ApS
Director, See Remarks
Y-mAbs Therapeutics, Inc.
(YMAB)
4,189,694
-3%
150,000
$35.99
$5,397,810.50
SELL
8 Jun 2021
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,189,694
-3%
150,000
$35.99
$5,397,810.50
SELL
7 Jun 2021
WG Biotech ApS
10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
4,339,694
-1%
72,400
$34.15
$2,472,583.00
SELL
7 Jun 2021
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,339,694
-1%
72,400
$34.15
$2,472,583.00
SELL
4 Jun 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
249,077
-1%
4,000
$33.48
$133,920.00
SELL
3 Jun 2021
WG Biotech ApS
10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
4,412,094
-0%
34,507
$33.28
$1,148,373.50
SELL
3 Jun 2021
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,412,094
-0%
34,507
$33.28
$1,148,373.50
SELL
28 May 2021
WG Biotech ApS
10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
4,446,601
-0%
31,864
$36.17
$1,152,648.10
SELL
28 May 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,603,927
-0%
4,000
$36.95
$147,813.20
SELL
28 May 2021
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
4,446,601
-0%
31,864
$36.17
$1,152,648.10
SELL
24 May 2021
Kruse Bo
EVP, CFO, Secretary & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
253,077
-1%
4,000
$35.61
$142,440.00
SELL
18 May 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,607,927
-0%
4,000
$34.07
$136,289.60
SELL
26 Apr 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
7,000
$27.96
$195,730.50
SELL
12 Apr 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$26.60
$292,641.20
SELL
1 Apr 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
15,000
$30.26
$453,946.20
SELL
15 Mar 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$36.79
$404,655.80
SELL
1 Mar 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
15,000
$35.51
$532,639.50
SELL
16 Feb 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$47.08
$517,922.60
SELL
1 Feb 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$41.98
$461,785.10
SELL
19 Jan 2021
GILL DAVID N
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
2,000
$46.52
$93,045.20
SELL
19 Jan 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$46.53
$511,793.38
SELL
5 Jan 2021
Gad Thomas
See remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
11,000
$49.34
$542,756.75
SELL
28 Dec 2020
Gad Thomas
See Remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
7,000
$51.98
$363,832.72
SELL
16 Dec 2020
Gad Thomas
See Remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
7,000
$53.01
$371,065.10
SELL
14 Dec 2020
Gad Thomas
See Remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(VYMAB)
618,000
-0%
4,000
$52.89
$211,545.60
SELL
10 Dec 2020
Gad Thomas
See Remarks, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
100,000
$50.96
$5,096,260.00
SELL
2 Dec 2020
Moller-San Pedro Claus Juan
Chief Executive Officer, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
607,303
-7%
50,000
$51.21
$2,560,621.80
SELL
1 Dec 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
622,000
-0%
4,000
$51.42
$205,685.20
SELL
18 Nov 2020
GILL DAVID N
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
2,000
$45.77
$91,530.00
BUY
17 Nov 2020
Rajah Vignesh
SVP and CMO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,697
+100%
1,697
$46.47
$78,853.35
SELL
16 Nov 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
626,000
-0%
4,000
$46.17
$184,671.60
SELL
3 Nov 2020
GILL DAVID N
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
4,000
$45.00
$180,000.00
SELL
2 Nov 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
630,000
-0%
4,000
$43.69
$174,768.80
SELL
15 Oct 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
634,000
-0%
4,000
$39.15
$156,603.61
SELL
1 Oct 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
638,000
-0%
4,000
$38.88
$155,524.40
SELL
15 Sep 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
642,000
-0%
4,000
$40.81
$163,224.80
SELL
10 Sep 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
50,000
$40.98
$2,049,116.50
SELL
1 Sep 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
646,000
-0%
4,000
$41.60
$166,390.39
SELL
17 Aug 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
650,000
-0%
4,000
$40.35
$161,392.00
SELL
11 Aug 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
654,000
-7%
50,000
$39.91
$1,995,678.90
SELL
3 Aug 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
704,000
-0%
4,000
$36.51
$146,026.00
SELL
15 Jul 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
708,000
-0%
4,000
$40.06
$160,229.20
SELL
1 Jul 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
712,000
-0%
4,000
$42.04
$168,178.00
SELL
15 Jun 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
716,000
-0%
4,000
$43.45
$173,811.20
SELL
4 Jun 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
720,000
-0%
4,000
$41.61
$166,443.61
SELL
27 May 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
724,000
-6%
50,000
$39.01
$1,950,460.00
SELL
26 May 2020
Ahmed Mahiuddin
Sr. VP and CSO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
150,000
-25%
50,000
$39.38
$1,969,235.00
SELL
18 May 2020
Ahmed Mahiuddin
Sr. VP and CSO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
200,000
-12%
29,492
$39.40
$1,162,077.80
SELL
18 May 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
774,000
-0%
4,000
$39.65
$158,596.00
SELL
13 May 2020
Kruse Bo
EVP, CFO, Secy & Treas., Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
257,077
-28%
100,000
$36.65
$3,665,321.00
SELL
13 May 2020
Ahmed Mahiuddin
Sr. VP & Chief Scientific Off, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
229,492
-4%
10,508
$37.64
$395,563.16
SELL
13 May 2020
Moller-San Pedro Claus Juan
Chief Executive Officer, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
657,303
-23%
200,000
$36.55
$7,310,120.00
SELL
12 May 2020
Ahmed Mahiuddin
Sr. VP and CSO, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
240,000
-7%
20,000
$39.19
$783,776.00
SELL
12 May 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
778,000
-6%
50,000
$39.04
$1,951,935.00
SELL
1 May 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
828,000
-0%
4,000
$32.35
$129,404.41
SELL
13 Apr 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
832,000
-0%
4,000
$29.43
$117,711.20
BUY
17 Mar 2020
Moller-San Pedro Claus Juan
Chief Executive Officer, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
1,900
+100%
1,900
$17.22
$32,711.54
SELL
16 Mar 2020
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
836,000
-0%
4,000
$18.01
$72,040.81
SELL
2 Mar 2020
Gad Thomas
President & Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
840,000
-0%
4,000
$29.18
$116,713.20
SELL
18 Feb 2020
Gad Thomas
President & Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
844,000
-0%
4,000
$32.78
$131,132.80
SELL
10 Feb 2020
Gad Thomas
President & Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
848,000
-0%
4,000
$33.03
$132,120.80
SELL
27 Jan 2020
Gad Thomas
President & Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
852,000
-0%
4,000
$35.06
$140,223.61
SELL
13 Jan 2020
Gad Thomas
President & Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
856,000
-0%
4,000
$30.90
$123,612.00
SELL
13 Dec 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
860,000
-0%
4,000
$31.54
$126,176.40
SELL
2 Dec 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
872,000
-0%
4,000
$32.48
$129,930.41
SELL
18 Nov 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
876,000
-0%
4,000
$28.41
$113,657.60
SELL
4 Nov 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
880,000
-0%
4,000
$30.10
$120,418.00
BUY
30 Oct 2019
HEALY JAMES
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
2,194,278
+4%
90,000
$28.00
$2,520,000.00
SELL
21 Oct 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
884,000
-0%
4,000
$27.59
$110,350.80
SELL
7 Oct 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
888,000
-0%
4,000
$25.21
$100,848.00
SELL
16 Sep 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
892,000
-0%
4,000
$30.59
$122,375.60
SELL
5 Sep 2019
Wedell-Wedellsborg Johan
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
498,392
-3%
17,243
$27.00
$465,561.00
SELL
3 Sep 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
896,000
-0%
4,000
$25.77
$103,080.81
SELL
29 Aug 2019
Raskin Gregory S
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
0
-100%
5,882
$26.70
$157,026.47
SELL
29 Aug 2019
Wedell-Wedellsborg Johan
Director, 10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
515,635
-14%
89,166
$26.58
$2,370,074.20
SELL
27 Aug 2019
Wedell-Wedellsborg Johan
Director, 10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
604,801
-7%
49,357
$27.08
$1,336,795.00
SELL
22 Aug 2019
Wedell-Wedellsborg Johan
Director, 10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
654,158
-0%
990
$27.75
$27,472.50
SELL
20 Aug 2019
Wedell-Wedellsborg Johan
Director, 10% Owner
Y-mAbs Therapeutics, Inc.
(YMAB)
664,147
-20%
168,244
$27.57
$4,637,898.00
SELL
19 Aug 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
900,000
-0%
4,000
$27.70
$110,804.81
SELL
5 Aug 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
904,000
-0%
4,000
$21.78
$87,105.60
SELL
22 Jul 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
908,000
-0%
4,000
$22.54
$90,176.81
SELL
8 Jul 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
912,000
-0%
4,000
$22.40
$89,591.60
SELL
24 Jun 2019
Gad Thomas
President and Chariman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
916,000
-0%
4,000
$21.77
$87,097.60
SELL
10 Jun 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
920,000
-0%
4,000
$22.79
$91,166.40
SELL
3 Jun 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
924,000
-0%
4,000
$20.03
$80,121.20
SELL
28 May 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
928,000
-0%
6,000
$20.21
$121,252.20
SELL
13 May 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
934,000
-0%
6,000
$20.61
$123,647.41
SELL
9 Apr 2019
Gad Thomas
President and Chairman, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
940,000
-21%
250,000
$25.89
$6,472,729.00
BUY
25 Sep 2018
TYAGI ASHU
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
1,392,740
+44%
430,174
$16.00
$6,882,784.00
BUY
25 Sep 2018
Juan Moller San Pedro Claus
Chief Executive Officer, Director, Officer
Y-mAbs Therapeutics, Inc.
(YMAB)
872,928
+3%
31,250
$16.00
$500,000.00
BUY
21 Sep 2018
HEALY JAMES
Director
Y-mAbs Therapeutics, Inc.
(YMAB)
2,104,278
+31%
500,000
$16.00
$8,000,000.00
Home